K191179

Substantially Equivalent

Myo Plus

Applicant: Otto Bock Healthcare Products GmbH
Product code: GXY
Advisory panel: Neurology
Date received: 2019-05-02
Decision date: 2019-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Vienna, AT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.